<SEC-DOCUMENT>0001140361-23-010614.txt : 20230308
<SEC-HEADER>0001140361-23-010614.hdr.sgml : 20230308
<ACCEPTANCE-DATETIME>20230308102008
ACCESSION NUMBER:		0001140361-23-010614
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230302
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230308
DATE AS OF CHANGE:		20230308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			U S PHYSICAL THERAPY INC /NV
		CENTRAL INDEX KEY:			0000885978
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				760364866
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11151
		FILM NUMBER:		23715081

	BUSINESS ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
		BUSINESS PHONE:		7132977000

	MAIL ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10049447_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:usph="http://usph.com/20230302" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e3cde890fc9e4e00be32c350e514c9a0" contextRef="c20230302to20230302" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_7da771b3ed264c4dac0fa80709e30e0e" contextRef="c20230302to20230302">U S PHYSICAL THERAPY INC /NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_3c0a3f5cb6a3464c8428037e4c1ee35c" contextRef="c20230302to20230302">0000885978</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="usph-20230302.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230302to20230302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-02</xbrli:startDate><xbrli:endDate>2023-03-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, DC 20549</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_5d955551b35e43e0a2b2a9c390160acb" contextRef="c20230302to20230302">8-K</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;<span style="font-weight: bold;">CURRENT REPORT</span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_c4ff5f1bf75740ad8b3d40e84dfb9937" contextRef="c20230302to20230302" format="ixt:date-monthname-day-year-en">March 2, 2023</ix:nonNumeric></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;">&#160;<span style="-sec-ix-hidden:Fact_7da771b3ed264c4dac0fa80709e30e0e">U.S. PHYSICAL THERAPY, INC.</span><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_da67f7823bf54065a947f1149b4b3d3f" contextRef="c20230302to20230302" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_2cc80f7945bd4bd28623c7624c1f7fb5" contextRef="c20230302to20230302">1-11151</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 32.57%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_01ce2723d5d846c68a13435131ade1ef" contextRef="c20230302to20230302">76-0364866</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(State or other jurisdiction of incorporation or organization)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Commission File Number)</div>
            </td>

    <td style="width: 32.57%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_758c16b2aa324f7681ad4f1545a3965e" contextRef="c20230302to20230302">1300 West Sam Houston Parkway South</ix:nonNumeric>,</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_1aa8dffc12314c0890dff786e60af20f" contextRef="c20230302to20230302">Suite 300</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_a4e5c0e2553f494bb3ceaf497a35b9e1" contextRef="c20230302to20230302">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_32f5090e7d92428ba9ea4d05ee6f9dce" contextRef="c20230302to20230302" format="ixt-sec:stateprovnameen">Texas</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_9a8d2dfb29d8470b8d5691ca7375d914" contextRef="c20230302to20230302">77042</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registrant's telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_28f525957ba24c36a064e9fcfa978de4" contextRef="c20230302to20230302">713</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_9dce485af0cd4c32bd10e7ee007903c7" contextRef="c20230302to20230302">297-7000</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions ( <span style="text-decoration: underline;">see</span> General Instruction A.2. below):</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_1b6d64d7cfed4332a2dab318978cb08b" contextRef="c20230302to20230302" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_6cf48518d06b44bbaf2287f091c10262" contextRef="c20230302to20230302" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_d58768e4db064090ad4b7311d8816818" contextRef="c20230302to20230302" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_0b7d6cdbe4bd4288b4b2d93b81369b22" contextRef="c20230302to20230302" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(35, 31, 32);">Title of each class</div>
            </td>

    <td style="width: 34%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(35, 31, 32);">Trading Symbol(s)</div>
            </td>

    <td style="width: 33%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(35, 31, 32);">Name of each exchange on which </div>
              <div style="text-align: center; color: rgb(35, 31, 32);">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_ac1797f4c66845db851f6e5719d887f4" contextRef="c20230302to20230302">Common Stock, $.01 par value</ix:nonNumeric><br />
            </td>

    <td style="width: 34%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_842cadaa61ff4904b3a28a173988b137" contextRef="c20230302to20230302">USPH</ix:nonNumeric><br />
            </td>

    <td style="width: 33%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_577d45e8dfcf4a1f9d09b6935307b0d8" contextRef="c20230302to20230302" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br />
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company</div>

      <div style="text-align: left; text-indent: -27pt; margin-right: 0.1pt; margin-left: 27.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_07189b3464314c87a3249da9016f8a8d" contextRef="c20230302to20230302" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
        any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744; </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify;"><br />
        </div>

        <div style="text-align: justify;">
          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter"></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader"></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Departure of Directors or Certain Officers&#894; Election of Directors&#894; Appointment of Certain Officers&#894; Compensatory Arrangements of Certain Officers.</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div>
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Compensatory Arrangements of Executive Officers</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_Hlk128665917"></a>Effective March 2, 2023, the Compensation Committee of the Board of Directors (the &#8220;Committee&#8221; as defined in Section 1.8
        of the U. S. Physical Therapy, Inc. (&#8220;USPH&#8221;) 2003 Stock Incentive Plan (the &#8220;2003 Plan&#8221;)) approved and adopted the incentive plans for senior management as described below. Members of senior management who are eligible under the incentive plans
        include Mr. Christopher Reading, Chief Executive Officer (&#8220;CEO&#8221;), Mr. Carey Hendrickson, Chief Financial Officer (&#8220;CFO&#8221;), Mr. Eric Williams, Chief Operating Officer - East (&#8220;COO East&#8221;), Mr. Graham Reeve, Chief Operating Officer &#8211; West (&#8220;COO West&#8221;),
        and Mr. Rick Binstein, Executive Vice President, General Counsel and Secretary (&#8220;EVP&#8221;), (hereinafter collectively referred to as &#8220;Executives&#8221;).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; margin-right: 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Objective Long- Term Incentive Plan for Senior
            Management for 2023 (&#8220;Objective LTIP&#8221;).</span>&#160;</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">Under this Objective LTIP, Executives have an opportunity to receive Restricted Stock Awards (&#8220;RSAs&#8221;) under the 2003 Plan to be
          granted by the Compensation Committee in the first quarter of 2024 subject to the continuous employment of the Executive by USPH or its affiliates from the Effective Date through the date of the grant of the RSA. All RSAs granted shall be in
          writing and subject to the terms of the 2003 Plan and the specific terms and conditions (including without limitation, restrictions in transfer and substantial risk of forfeiture) as determined by the Compensation Committee in its sole
          discretion. The RSAs will vest evenly over 16 quarters, beginning April 1, 2024, and ending January 1, 2028, subject to acceleration of vesting in the Committee&#8217;s sole discretion and based on the occurrence of certain events, as more specifically
          defined in the applicable Restricted Stock Agreement between the Executive and USPH and/or in the Executive's employment agreement with USPH.&#160; The number of RSAs that may be granted is subject to the achievement of Adjusted EBITDA for the year
          2023 and may range between 30% to 100% of the maximum number of shares. The maximum number of RSAs that may be granted are as follows: CEO = 10,000 shares; CFO = 5,000 shares; COO East = 5,000 shares; COO West = 5,000 shares and EVP = 5,000
          shares.</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; margin-right: 0.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic; color: #000000;"><span style="text-decoration: underline;">Discretionary Long-Term Incentive Plan for
            Senior Management for 2023 (&#8220;Discretionary LTIP&#8221;).</span>&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">In addition to any other awards under the 2003 Plan or any other long term incentive plan or bonus
          plan, policy, or program of USPH, and not in lieu of any other such award or payment, the Compensation Committee may, in its judgment and at its sole discretion, grant RSAs under the 2003 Plan, based on its evaluation of an Executive's
          performance and the collective corporate performance for 2023.</span><span style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Any RSAs granted under this
          program shall be awarded in the first quarter of 2024 subject to the continuous employment of the Executive by USPH or its affiliates from the Effective Date through the date of the grant of the RSA. All RSAs granted shall be in writing and
          subject to the terms of the 2003 Plan and the specific terms and conditions (including without limitation, restrictions in transfer and substantial risk of forfeiture) as determined by the Compensation Committee in its sole discretion. RSAs
          granted under this Discretionary LTIP will vest evenly over 16 quarters, beginning April 1, 2024, and ending January 1, 2028, subject to acceleration of vesting based on the occurrence of certain events, as more specifically defined in the
          applicable Restricted Stock Agreement between the Executive and USPH and/or in the Executive's employment agreement with USPH.&#160; The number of RSAs that may be granted is subject to the evaluation of the Executive&#8217;s performance and the collective
          corporate performance during 2023. The maximum number of RSAs that may be granted are as follows: CEO = up to 10,000 shares; CFO = up to 5,000 shares; COO West = up to 5,000 shares; COO East = up to 5,000 shares, and EVP = up to 5,000 shares.</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; margin-right: 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Objective Cash/RSA Bonus Plan for Senior
            Management for 2023 ("Objective Cash/RSA Bonus Plan&#8221;).</span>&#160;</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">Under this Objective Cash/RSA Bonus Plan, Executives have an opportunity to receive either a "Cash Bonus" Award or
          RSAs having a value at the time of the Award of up to 75% of the CEO, COO West, COO East, CFO and EVP annual base salary for 2023 as Performance Awards under the 2003 Plan. The Compensation Committee will, in its sole discretion, determine the
          amount and type of award to be made in the first quarter of 2024. No Executive will be entitled to any type of award or have a legally binding right to an award until the Compensation Committee, in its sole discretion, determines an award will be
          made, the amount and the type of award to be made. No Executive will be entitled to elect between the Cash Bonus and RSA. Before any Cash Bonus is made or an RSA is awarded under this Objective Cash/RSA Bonus Plan, the Compensation Committee
          shall certify in writing that the performance goals have been obtained. Any Cash Bonus award made hereunder shall be paid in a lump-sum amount, and any RSA granted, in each case no later than March 14, 2024. The Executive must be continuously
          employed by USPH or its affiliates from the Effective Date through December 31, 2023 to receive the Cash Bonus or an RSA.</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter"></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader"></div>

      </div>

      <div style="text-align: left; margin-right: 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Discretionary Cash/RSA Bonus Plan for Senior
            Management for 2023 ("Discretionary Bonus Plan")</span></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">.</span> In addition to awards under any other plan or program at USPH for which such Executives are eligible and not in
          lieu thereof, each Participant in this Discretionary Bonus Plan has the potential to be awarded of up to 50% of the Participant's annual base salary for 2023 (&#8220;Subjective Bonus&#8221;) subject to the achievement of individual goals established by the
          Compensation Committee. The Subjective Bonus shall be made as either a Cash Bonus Award or RSAs, as determined in the sole discretion of the Compensation Committee. The Compensation Committee shall have the sole discretion to determine the amount
          and type of award (whether a Cash Bonus Award or an RSA) will be made. No Participant shall be entitled to a Subjective Bonus and shall have no legally binding right to a Subjective Bonus until the Compensation Committee determines the amount and
          type of award to be made.&#160; No Participant will be entitled to elect any type of award to be made.</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing descriptions are qualified in its entirety by reference to the full text of each of the Objective LTIP, Discretionary LTIP, Objective
        Cash/RSA Bonus Plan, and Discretionary Bonus Plan, which are filed as Exhibits 99.1, 99.2, 99.3 and 99.4, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ITEM 9.01</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCIAL STATEMENTS AND EXHIBITS</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 9%;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Exhibits</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Description of Exhibits</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; width: 9%;">&#160;</td>

    <td colspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; width: 1%;">&#160;</td>

    <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; width: 90%;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 9%;">
              <div style="text-align: left;"><a href="brhc10049447_ex99-1.htm">99.1*</a></div>
            </td>

    <td colspan="1" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 1%;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2023, effective March 2, 2023.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="brhc10049447_ex99-2.htm">99.2*</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 90%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2023, effective March 2, 2023.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="brhc10049447_ex99-3.htm">99.3*</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 90%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2023, effective March 2, 2023.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><a href="brhc10049447_ex99-4.htm">99.4*</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 90%;">
              <div style="text-align: left; color: rgb(0, 0, 0);">U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2023, effective March 2, 2023.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">* Filed herewith</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter"></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div class="BRPFPageHeader"></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">U.S. PHYSICAL THERAPY, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Dated: March 8, 2023</div>
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">/s/ CAREY HENDRICKSON</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Carey Hendrickson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">(duly authorized officer and principal financial and accounting officer)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10049447_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" style="height: 4px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: right; margin-left: auto; margin-right: auto; border: medium none;">
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: right;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left;">
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. (&#8220;USPH&#8221;)</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OBJECTIVE LONG-TERM INCENTIVE PLAN FOR SENIOR MANAGEMENT</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR 2023 (&#8220;Objective LTIP&#8221;)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purpose</u></font><font style="font-size: 10pt;">: To incentivize and retain Executives eligible for
          this Objective LTIP, to achieve certain corporate earnings criteria and reward Executives when such criteria are achieved, and to align the&#160; long-term interests of Executives and shareholders of USPH by compensating the Executives in shares of
          USPH stock that vest over time, thereby increasing the Executives' equity interest in USPH.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effective Date</u></font><font style="font-size: 10pt;">: The effective date of this Objective LTIP and
          the establishment of performance goals and formula for the amount payable hereunder is March 2, 2023.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Eligibility</u></font><font style="font-size: 10pt;">: The Executives of USPH eligible for this
          Objective LTIP are the Chief Executive Officer ("CEO"), the Chief Financial Officer ("CFO"), the General Counsel ("EVP"), the Chief Operating Officer West ("COO West") and the Chief Operating Officer East ("COO East"). Terms not defined herein
          shall have the meaning of such term as defined in the U.S. Physical Therapy, Inc. 2003 Stock Incentive Plan (as amended) (the "2003 Plan").</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Vesting and Other Terms and Provisions</u></font><font style="font-size: 10pt;">: Under this Objective
          LTIP, Executives have an opportunity to receive Restricted Stock Awards ("RSAs") under the U. S. Physical Therapy, Inc. 2003 Stock Incentive Plan (as amended) (the "2003 Plan"), to be granted by the Compensation Committee of the Board of
          Directors of USPH (as the term "Committee&#8221; is defined in Section 1.8 of the 2003 Plan) in the first quarter of 2024. The Executive must be employed by USPH or its affiliates from the Effective Date through the date of the grant to receive a RSA.
          All RSAs shall be granted subject to the terms of the 2003 Plan and the specific terms and conditions (including without limitation, restrictions in&#160; transfer&#160; and substantial&#160; risk of forfeiture)&#160; as determined&#160; by the Compensation&#160; Committee in
          its sole discretion. RSAs that are granted under this Objective LTIP will vest evenly over 16 quarters, beginning April 1, 2024 and ending January 1, 2028, subject to acceleration of vesting in the Committee's sole discretion and based on the
          occurrence of certain events, as more specifically defined in the applicable Restricted Stock Agreement between the Executive and USPH and/or in the Executive's employment agreement with USPH.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Administration</u></font><font style="font-size: 10pt;">: The Compensation Committee has authority to
          administer this Objective LTIP, grant awards and decide all questions of interpretation. The Compensation Committee shall set out the vesting and other terms of an RSA in writing. The Compensation Committee's determinations and interpretations
          under this Objective LTIP</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Objective Goals And Amounts That May Be Awarded</u></font><font style="font-size: 10pt;">: The
          maximum amount of RSAs that may be granted under this this Objective LTIP based on achievement of the performance goals relating&#160; to 2023 are as follows: CEO = 10,000 shares; CFO = 5,000&#160; shares; COO East = 5,000 shares; COO West = 5,000 shares
          and EVP = 5,000 shares</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Award Grant Date</u></font><font style="font-size: 10pt;">:&#160; Any RSAs granted under this program shall
          be granted under the 2003 Plan in the first quarter of 2024 after the Compensation Committee determines the amount, if any, of the RSAs to be granted to each Participant. In addition, RSAs shall be granted only if the participant remains employed
          by USPH (or its affiliates) continuously from the Effective Date through the date of the grant of the RSA. All RSAs shall be granted in writing and subject to the terms of the 2003 Plan and the specific terms and conditions (including without
          limitation, restrictions in transfer and substantial risk of forfeiture) as determined by the Compensation Committee in its sole discretion. RSAs that are granted under this Objective LTIP will vest evenly over 16 quarters, beginning April 1,
          2024 and ending January 1, 2028, subject to acceleration of vesting based on the occurrence of certain events, as more specifically defined in the applicable Restricted Stock Agreement between the Executive and USPH and/or in the Executive's
          employment agreement with USPH.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 50%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="zed781c1b095d4589ab91aa1934ccc3cb" class="cfttable">

            <tr>
              <td valign="bottom" style="vertical-align: top;" colspan="2">

                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Performance Goals</div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjusted EBITDA</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="vertical-align: middle;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Objective</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount of Maximum Shares</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CEO, COOs, CFO, EVP</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">74,597,377</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">30.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">75,345,215</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">34.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">75,721,194</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">38.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">76,100,351</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">42.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">76,481,054</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">46.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">76,863,458</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">50.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">77,247,776</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">56.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">77,634,015</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">62.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">78,022,166</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">68.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">78,804,357</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">84.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 25%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman'; text-align: left;">79,198,378</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">92.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: middle; font-size: 10pt;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; text-indent: 2pt;">$79,594,370 AND OVER</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 20%;" colspan="1" class="cftnumcell">
                <div style="font-family: 'Times New Roman';">100.0</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt; clear: both;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Adjusted EBITDA is defined as net income attributable to USPH shareholders before interest income, interest expense, taxes, depreciation, and amortization, changes in
        revaluation of put-right liability, equity-based awards compensation expense, and other extraordinary or unusual items, and related portion for non-controlling interests.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>brhc10049447_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 99.2</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. (&#8220;USPH&#8221;)</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DISCRETIONARY LONG-TERM INCENTIVE PLAN FOR SENIOR MANAGEMENT</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR 2023 (&#8220;Discretionary LTIP&#8221;)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purpose</u></font><font style="font-size: 10pt;">: To incentivize Executives eligible for this
          Discretionary LTIP to achieve certain strategic, operational, business growth &amp; development and other criteria and reward Executives when such criteria are achieved, and to align the long-term interests of Executives and shareholders of USPH
          by compensating the Executives in shares of USPH stock that vest over time, thereby increasing the Executives' equity interest in USPH.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effective Date</u></font><font style="font-size: 10pt;">: This Discretionary LTIP is established
          effective March 2, 2023.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Description of Discretionary Awards Criteria</u></font><font style="font-size: 10pt;">: In addition to
          any other awards under the U.S. Physical Therapy, Inc. 2003 Stock Incentive Plan (as amended) (the "2003 Plan") or any other long term incentive plan or bonus plan, policy or program of USPH, and not in lieu of any other such award or payment,
          the Compensation Committee of the Board of Directors of USPH (as the term "Committee" is defined in Section 1.8 of the 2003 Plan) may, in its judgment and at its sole discretion, grant Restricted Stock Awards ("RSAs") under the 2003 Plan, based
          on its evaluation of an Executive's performance and the collective corporate performance for 2023. The factors to be considered include:</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>CEO</u></div>
      <br>
      <table cellspacing="0" cellpadding="0" id="z21050aee0cad45059a6af8b895b115aa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Company Leadership</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z2b7588004592477a839a16364c6e39fe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Cost Aligned with Revenue and Volume Growth</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zf5e0c084cc7e4b8c9b1c9f0e22158284" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Continued development of COO's (or direct reports)</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zba8840e80aaf42edb019a9542ef002c2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Maintain effective Compliance Culture</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z0fb90187a97e42c99e42e8746daaf334" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Acquisition, Tuck in and De Novo Development</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z3fd6c893456f45dd933a802187ddd185" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Buffer net rate impact with rate strategies and initiatives</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <u></u>





      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>CFO</u></div>
      <u> </u>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7f0163fc003e4f94b61913794e85eafb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Rate negotiations through strategic negotiations along with purging of sub-optimal contracts</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="za924228714a84050b4fd8914441678b4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Effective and accurate Board and Shareholder communication, guidance, modeling, projections and planning</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z1948b06577a841a098a461df909dfa14" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Improve efficiencies in Finance/AP and IT areas through technology improvements and staffing adjustments</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z245b292157b54a4a854923572cae67a1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Maintain effective capital structure to allow for continued growth</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z0e8066f251fb4d3dad85d0402d240f2d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Enact cost improvement opportunities across the company and within the corporate services area</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z9858a545a5a04804a2ed5fee64f213c6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;">Successful Audit implementation</div>
            </td>
          </tr>

      </table>
      <u> </u>






      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; font-size: 10pt;"><img width="40" height="12" src="image0.jpg"></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" id="z7d02f1dc61f64ed881188faf8f7d8428" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Align cost and revenue growth for Physical Therapy</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z6ffd23a5c40e4b11a1fa5aff1056427f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Create development plan for top 30 partnerships to ensure organic as well as acquired growth</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z13e7a4cac95c41708619641151f27845" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Work on IIP opportunities for sales and expansion and cost efficiency in light of broad economic environment</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z363b27c09a094fe5a40c98794d9da34b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Leadership development, succession and effective relationship integration to allow for seamless transitions to accommodate growth and succession-related changes</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z4ee722893cc6432281321f39603f1019" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Maintain effective compliance culture</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zb0092dc5a7b04b7eb3c20a29aae8a5ed" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Effective acquisition-related due diligence and integrated coordination and execution</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>EVP General Counsel</u></div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z28daaf5e6bea49c2906730a64482ac81" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Coordinate with CEO and other executives to facilitate growth through development</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zf161f7338c114680a426050c924afc6a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Assist in any compliance matters as needed to maintain an effective compliance culture and assist in any communications internally as needed with CCO (&#8220;Chief Compliance Officer&#8221;)
                  and executive team</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z66422eeba8d347c09821a601245f9b2b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Maintain legal department in a manner which successfully supports our partners as well as our corporate and infrastructure needs</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z35cb3f7ed55c48248ee30d9ca3afc32b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">Assist CEO and other executives in evaluating new opportunities for growth whether acquired or home grown</div>
              </td>
            </tr>

        </table>
      </div>






      <br>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Participants</u></font><font style="font-size: 10pt;">: Executives who will have an opportunity to be
          granted RSAs under this Discretionary LTIP shall be the Chief Executive Officer ("CEO"), the Chief Financial Officer ("CFO"), the Chief Operating Officer West ("COO West"), the Chief Operating Officer East ("COO East") and Executive Vice
          President, General Counsel (EVP). The following shall be the maximum amount of shares that may be awarded under this program to each specified participant: CEO= up to 10,000 shares; CFO= up to 5,000 shares; COO West= up to 5,000 shares; COO East=
          up to 5,000 shares, and EVP= up to 5,000 shares</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Administration</u></font><font style="font-size: 10pt;">: The Compensation Committee shall administer
          this Discretionary LTIP. The Compensation Committee shall have the exclusive authority to interpret and construe the terms of this Discretionary LTIP and make all determinations under this plan, and its decisions shall be final and binding in all
          persons. The Compensation Committee shall set out the vesting and other terms of an RSA in writing.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Award Grant Date</u></font><font style="font-size: 10pt;">:&#160; Any RSAs granted under this program shall
          be granted under the 2003 Plan in the first quarter of 2024 after the Compensation Committee determines the amount, if any, of the RSAs to be granted to each participant. In addition, RSAs shall be granted only if the participant remains employed
          by USPH (or its affiliates) continuously from the Effective Date through the date of the grant of the RSA. All RSAs shall be granted in writing and subject to the terms of the 2003 Plan and the specific terms and conditions (including without
          limitation, restrictions in transfer and substantial risk of forfeiture) as determined by the Compensation Committee in its sole discretion. RSAs that are granted under this Objective LTIP will vest evenly over 16 quarters, beginning April 1,
          2024 and ending January 1, 2028, subject to acceleration of vesting based on the occurrence of certain events, as more specifically defined in the applicable Restricted Stock Agreement between the Executive and USPH and/or in the Executive's
          employment agreement with USPH.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Certain Tax Considerations</u></font><font style="font-size: 10pt;">: Any awards actually granted under
          this program shall be subject to Code Section 83(b).</font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <font style="font-size: 10pt;"> <br>
      </font>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-size: 10pt;"> </font></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>brhc10049447_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; Exhibit 99.3</font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. (&#8220;USPH&#8221;)</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';">OBJECTIVE CASH/RSA BONUS PLAN FOR SENIOR MANAGEMENT</font></div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR 2023 (&#8220;OBJECTIVE BONUS PLAN&#8221;)</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>&#160;</u></font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purpose</u>:
        To incentivize and retain Executives eligible for this Objective Bonus Plan to achieve certain corporate earnings criteria and reward Executive Officers of USPH when such criteria are achieved, and to align the long-term interests of Executives and
        shareholders of USPH.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effective Date</u>: The effective date of this Objective Bonus Plan and the establishment of performance
        goals and formula for the amount payable hereunder is March 2, 2023.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Eligibility</u>: The Executives of USPH eligible for this Objective Bonus Plan are the Chief Executive
        Officer ("CEO"), the Chief Financial Officer ("CFO"),&#160; the Chief Operating Officer West ("COO West"), the Chief Operating Officer East ("COO East") and the Executive Vice President, General Counsel ("EVP")</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Description. Conditions and Payment Date</u>: Under this Objective Bonus Plan, Executives have an
        opportunity to receive either a "Cash Bonus" Award or to be granted a Restricted Stock Award ("RSA") having a value at the time of the Award of up to 75% of the annual base salary for 2023 (&#8220;Base&#8221;) for the CEO, COO West, COO East, CFO and EVP as
        Performance Awards under the 2003 Plan. The Compensation Committee of the Board of Directors of USPH (the "Compensation Committee") will, in its sole discretion, determine the amount and type of award to be made in the first quarter of 2024. No
        Executive will be entitled to any type of award or have a legally binding right to an award until the Compensation Committee, in its sole discretion, determines an award will be made, the amount and the type of award to be made. No Executive will
        be entitled to elect between the Cash Bonus and RSA. Before any Cash Bonus is made or an RSA is awarded under this Objective Bonus Plan, the Compensation Committee shall certify in writing that the performance goals have been obtained. Any Cash
        Bonus award made hereunder shall be paid in a lump-sum amount, and any RSA granted, in each case no later than March 14, 2024. The Executive must be continuously employed by USPH or its affiliates from the Effective Date through December 31, 2023
        to receive the Cash Bonus or an RSA.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Administration</u>:&#160; The Compensation Committee has authority to administer this Objective Bonus Plan,
        grant awards, determine whether any such awards shall be made as a Cash Bonus Award or as an RSA, and decide all questions of interpretation. The Compensation Committee shall set out the vesting and other terms of an RSA in writing. The
        Compensation Committee&#8217;s determinations and interpretations under this Objective Bonus Plan shall be final and binding on all persons.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Objective Bonus Calculation</u>:</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </div>
    <div style="margin-left: 27pt;">
      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="za97845788e1148cebb59dcccbce61b85" style="width: 30%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

          <tr>
            <td valign="bottom" colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">2023 Adjusted</div>
              <div style="text-align: left;">EBITDA</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td style="vertical-align: top; white-space: nowrap;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Potential Bonus Value</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(percentage of base salary)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">74,597,377</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 60.34%; background-color: rgb(204, 238, 255);" colspan="1">15.0%<br>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">75,345,215</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: left; width: 60.34%;">17.0%</td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">75,721,317</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: left; width: 60.34%; background-color: rgb(204, 238, 255);">19.0%</td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">76,100,551</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">21.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">76,481,054</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">23.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">76,863,458</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">25.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">77,247,776</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">28.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">77,634,015</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">31.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">78,022,166</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">34.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">78,412,296</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">38.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">78,804,357</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">42.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">79,198,378</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">46.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">79,594,370</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">50.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">79,992,343</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">54.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">80.372,304</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">58.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">80,794,265</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">62.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">81,198,236</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">66.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%;">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%;">
              <div style="text-align: left;">81,604,227</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%;">
              <div style="text-align: left;">70.0%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 3.79%; background-color: rgb(204, 238, 255);">
              <div>$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 31.38%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">82,012,249</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; width: 2.41%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; text-align: right; width: 60.34%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">75.0%</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; clear: both;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Adjusted EBITDA is defined as net income attributable to USPH shareholders before interest income, interest expense, taxes, depreciation, and amortization, changes in
      revaluation of put-right liability, equity-based awards compensation expense, and other extraordinary or unusual items, and related portion for non-controlling interests.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Trust or Fund</u>: There shall be no separate trust or fund for this Objective Bonus Plan. Any amount
        payable hereunder shall be an unfunded obligation of USPH and shall be payable out of the general assets of USPH and no amount payable shall be assignable by the participant.</font></div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">All RSAs shall be granted subject to the terms of the 2003 Plan and the specific terms and conditions (including without limitation, restrictions in transfer and
      substantial risk of forfeiture) as determined by the Compensation Committee in its sole discretion.</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>brhc10049447_ex99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 23.2.1.5134
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; text-indent: 35.9pt; margin-left: 288.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 99.4</div>
      <div style="text-align: right; text-indent: 35.9pt; margin-left: 288.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. (&#8220;USPH&#8221;)</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DISCRETIONARY CASH/RSA BONUS PLAN FOR SENIOR MANAGEMENT</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR 2023 (&#8220;DISCRETIONARY BONUS PLAN&#8221;)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purpose</u></font><font style="font-size: 10pt;">:&#160; The purpose of this
          Discretionary Bonus Plan is to retain and incentivize the Executive Officers of USPH by providing an annual bonus opportunity to the Executives to reward them when certain individual and corporate subjective performance measures are achieved.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Participants:</u></font><font style="font-size: 10pt;"> Executives of USPH who
          shall be "Participants" in this Discretionary Bonus Plan are the Chief Executive Officer ("CEO"), Chief Financial Officer ("CFO"), Chief Operating Officer West ("COO West"), Chief Operating Officer East ("COO East") and Executive Vice President,
          General Counsel (EVP). In addition to awards under any other plan or program at USPH for which such Executives are eligible and not in lieu thereof, each Participant in this Discretionary Bonus Plan has the potential to be awarded a "Subjective
          Bonus" of up to 50% of the Participant's annual base salary for 2023 ("Base") pursuant to the subjective criteria as set forth below. The Subjective Bonus shall be made as either a "Cash Bonus" Award or a Restricted Stock Award ("RSA"), as
          determined in the sole discretion of the Compensation Committee of the Board of Directors of USPH (the "Compensation Committee"). The Compensation Committee shall have the sole discretion to determine the amount and type of award (whether a Cash
          Bonus Award or an RSA) will be made. No Participant shall be entitled to a Subjective Bonus and shall have no legally binding right to a Subjective Bonus until the Compensation Committee determines the amount and type of award to be made.&#160; No
          Participant will be entitled to elect any type of award to be made.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effective Date</u></font><font style="font-size: 10pt;">: This Discretionary Bonus
          Plan is established effective March 2, 2023.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Administration</u></font><font style="font-size: 10pt;">: The Compensation Committee
          shall administer this Discretionary Bonus Plan and shall have the sole authority to interpret and construe all of the terms of this Discretionary Bonus Plan, establish the criteria for awards, determine the amounts payable under this plan, and
          determine whether such awards under this plan shall be made as a Cash Bonus Award or as an RSA. The amount, if any, of the Subjective Bonus payable to each participant in this Discretionary Bonus Plan shall be determined by the Compensation
          Committee in its sole discretion based upon subjective criteria described below. All decisions of the Compensation Committee shall be final and binding on all persons.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Award and Payment Date</u></font><font style="font-size: 10pt;">: The Compensation
          Committee shall make award determinations in the first quarter of 2024. After the Compensation Committee has determined that goals have been met and has calculated the awards to be made hereunder, the Cash Bonus Award shall be paid, and the RSA
          shall be granted to the applicable Participant in the first quarter of 2024 but no later than March 14, 2024. A Subjective Bonus shall be payable only if the Participant remains continuously employed from the Effective Date through the date of
          the determination of the amount payable by the Compensation Committee.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Subjective Bonus Calculation</u></font><font style="font-size: 10pt;">: The
          Subjective Bonus criteria that have been established by the Compensation Committee and shall be used in the Compensation Committee's sole discretion to grant an award of a Subjective Bonus having a value as of the date of the award of up to 50%
          of Base for CEO, COO West, COO East, CFO and EVP are as follows:</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>CEO</u></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u> <br>
        </u></div>
      <table cellspacing="0" cellpadding="0" id="z802739208a8d4f4a87aa38b50f02a328" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Company&#160; Leadership</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z1bd201258eb54c25a4859091098c0d64" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Cost Aligned with Revenue and Volume Growth</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z7467b934461947a995090149005762d6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Continued development of COO's (or direct reports)</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zf05cf7dabbbd4dd7ae7256452f46fdcf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Maintain effective Compliance Culture</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z92c81b5ee19d410090a6985d1ae8a8de" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Acquisition, Tuck in and De Novo Development</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zc383d6c32fc74d31bee927eabda1d7fd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Buffer net rate impact with rate strategies and initiatives</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>CFO</u></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u> <br>
        </u></div>
      <table cellspacing="0" cellpadding="0" id="z515a21758f8e4e189d1107cbefecfef5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Rate negotiations through strategic negotiations along with purging of sub-optimal contracts</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z2880d9694c9b47829ed56ace396b0492" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Effective and accurate Board and Shareholder communication, guidance, modeling, projections and planning</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zcccd9897bf6c4b5faf6f9331f8b285d8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Improve efficiencies in Finance/AP and IT areas through technology improvements and staffing adjustments</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z5029c3e103464dccab7534b95b68616a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Maintain effective capital structure to allow for continued growth</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z5c35403697154b7badfe5158f88d4d9e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Enact cost improvement opportunities across the company and within the corp services area</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z08984cae547f41aab8efc348e3a921db" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Successful Audit implementation</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>COO&#8217;s</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z7e7894a3162d491ba73d23d3c196f8c0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Align cost and revenue growth for Physical Therapy</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z74a90b84b98444bfbe747aa4b60970c1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Create development plan for top 30 partnerships to ensure organic as well as acquired growth</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="za5208b83ce17431a88ee539a1948a3d3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Work on IIP opportunities for sales and expansion and cost efficiency in light of broad economic environment</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zbccd5f697abc49258cd7ca1f7ea61015" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Leadership development, succession and effective relationship integration to allow for seamless transitions to accommodate growth and succession-related changes</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zf71ad3711f654240bb07cdb9160e991f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Maintain effective compliance culture</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z58de6ae0857b4f9782893d11c5bd6c96" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Effective acquisition-related due diligence and integrated coordination and execution</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>EVP General Counsel</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z5e365008e68f4f33b137f17e2028e578" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Coordinate with CEO and other executives to facilitate growth through development</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zaee12e499eb340a7b60b7d9d65c16ee7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Assist in any compliance matters as needed to maintain an effective compliance culture and assist in any communications internally as needed with CCO and executive team</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z93f2465005c347deb9bef3548598b50d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Maintain legal department in a manner which successfully supports our partners as well as our corporate and infrastructure needs</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z3478c61f391448458f6ae1ac04c5c464" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Assist CEO and other executives in evaluating new opportunities for growth whether acquired or home grown</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Trust or Fund</u></font><font style="font-size: 10pt;">: There shall be no
          separate trust or fund for this Objective Bonus Plan. Any amount payable hereunder shall be an unfunded obligation of USPH and shall be payable out of the general assets of USPH and no amount payable shall be assignable by the participants:</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">All RSAs shall be granted subject to the terms of the 2003 Plan and the specific terms and conditions (including without limitation, restrictions in transfer
        and substantial risk of forfeiture) as determined by the Compensation Committee in its sole discretion.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>usph-20230302.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<xs:schema targetNamespace="http://usph.com/20230302" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:usph="http://usph.com/20230302" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20230302_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20230302_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://usph.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>usph-20230302_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>usph-20230302_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.2.1.5134 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20230302.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H ( # 2(  A$! Q$!_\0
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MQ!*J"0FY Q.?[BC/ R >M^/O'VF_#_1H[V]BDN)[AVCMK:)U#.P4G)R<A <
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M42G]Z^3@9/.U0=HZ=S@%C0!Y!\, GAC]H+6M&G@G1KC[7:V^85CX#B56*J%
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K.<OO[#P?_P )3_8\W_"7?8?[0^UR^7]BSL\G=\G7\<=]NW=\VZBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140496951637168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  02,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">U S PHYSICAL THERAPY INC /NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0364866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1300 West Sam Houston Parkway South<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">297-7000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">USPH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>brhc10049447_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="usph-20230302.xsd" xlink:type="simple"/>
    <context id="c20230302to20230302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2023-03-02</startDate>
            <endDate>2023-03-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230302to20230302"
      id="Fact_e3cde890fc9e4e00be32c350e514c9a0">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="c20230302to20230302"
      id="Fact_7da771b3ed264c4dac0fa80709e30e0e">U S PHYSICAL THERAPY INC /NV</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20230302to20230302"
      id="Fact_3c0a3f5cb6a3464c8428037e4c1ee35c">0000885978</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20230302to20230302"
      id="Fact_5d955551b35e43e0a2b2a9c390160acb">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230302to20230302"
      id="Fact_c4ff5f1bf75740ad8b3d40e84dfb9937">2023-03-02</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230302to20230302"
      id="Fact_da67f7823bf54065a947f1149b4b3d3f">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230302to20230302"
      id="Fact_2cc80f7945bd4bd28623c7624c1f7fb5">1-11151</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230302to20230302"
      id="Fact_01ce2723d5d846c68a13435131ade1ef">76-0364866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230302to20230302"
      id="Fact_758c16b2aa324f7681ad4f1545a3965e">1300 West Sam Houston Parkway South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20230302to20230302"
      id="Fact_1aa8dffc12314c0890dff786e60af20f">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20230302to20230302"
      id="Fact_a4e5c0e2553f494bb3ceaf497a35b9e1">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230302to20230302"
      id="Fact_32f5090e7d92428ba9ea4d05ee6f9dce">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230302to20230302"
      id="Fact_9a8d2dfb29d8470b8d5691ca7375d914">77042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230302to20230302"
      id="Fact_28f525957ba24c36a064e9fcfa978de4">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230302to20230302"
      id="Fact_9dce485af0cd4c32bd10e7ee007903c7">297-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230302to20230302"
      id="Fact_1b6d64d7cfed4332a2dab318978cb08b">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230302to20230302"
      id="Fact_6cf48518d06b44bbaf2287f091c10262">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230302to20230302"
      id="Fact_d58768e4db064090ad4b7311d8816818">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230302to20230302"
      id="Fact_0b7d6cdbe4bd4288b4b2d93b81369b22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230302to20230302"
      id="Fact_ac1797f4c66845db851f6e5719d887f4">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230302to20230302"
      id="Fact_842cadaa61ff4904b3a28a173988b137">USPH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230302to20230302"
      id="Fact_577d45e8dfcf4a1f9d09b6935307b0d8">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230302to20230302"
      id="Fact_07189b3464314c87a3249da9016f8a8d">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (-2:%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "#4FA6J",N,.T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)VU1)'1S43PI""XHWD(RNQMLTI",M/OVIG&WB^@#"+EDYL\W
MWT!Z'80>(S[',6 DB^EJ=H-/0H<-.Q % 9#T 9U*=4[XW-R-T2G*U[B'H/2'
MVB.TG-^ 0U)&D8(%6(65R&1OM- 1%8WQA#=ZQ8?/.!28T8 #.O24H*D;8'*9
M&([ST,,%L, (HTO?!30KL53_Q)8.L%-R3G9-3=-43UW)Y1T:>'MZ?"GK5M8G
M4EYC?I6LH&/ #3M/?NWN[K</3+:\[2J>S^VVN18M%[QY7UQ_^%V$W6CLSOYC
MX[.@[.'7OY!?4$L#!!0    ( (-2:%:97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M@U)H5A#O!A]P!   /Q$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF&]SXC80QK^*QNUTVIDDM@P!DA)F."ZY,)?+>6)R:=KI"V$+T,2V7$D.X=MW
M98A-4[,F+X+_:!__O%J>E1BNI7K1*\X->4N33%\Y*V/R2]?5T8JG3)_)G&=P
M9R%5R@R<JJ6K<\597 :EB>M[7L]-F<B<T;"\%JC14!8F$1D/%-%%FC*U^<03
MN;YRJ/-^X4$L5\9><$?#G"UYR,UC'B@X<RN56*0\TT)F1/'%E3.FEY_\<QM0
MCO@A^%KO'1/[*G,I7^S)-+YR/$O$$QX9*\'@XY5/>))8)>#X9R?J5,^T@?O'
M[^HWY<O#R\R9YA.9/(G8K*Z<@4-BOF!%8A[D^I;O7J@$C&2BR_]DO1W;[3HD
M*K21Z2X8"%*1;3_9VRX1>P&=WH$ ?Q?@E]S;!Y64GYEAHZ&2:Z+L:%"S!^6K
MEM$ )S([*Z%1<%= G!E]EE$!23:$93&YSHPP&S+-MK,-61NZ!AYBA[K13O#3
M5M _(/B-J3/B^2?$]_S.?\-=8*L _0K0+_4Z!_0F\I4K\M=XKHV"*?R[B6BK
MT&U6L'5]J7,6\2L'"E=S]<J=T2\_T9[W.\+7J?@ZF'J=P-DFYTUP>/C@]"L"
MT:T@NJC*& CBDN(F8<LF"CQ^P1+-$8[SBN/\N&0$7 EI"RHF4):-><&5RC(J
MZZBMD'H56P]5W!7WC4@XN2_2.5=-5+@&/:64GE.$IE_1](^A>>!+80L;4G;/
MTL8\X3J/)"3![7,XG8SOR.SV^F$</)/I_82X]S\0S$&%.3@&<P)SJE@"SA#S
M-_*5;YI <24/_@:#\XO^ ,&ZJ+ NCL&:9I%4N52E59V0T$"I$:G(1!; "]@R
M;DPI+HXFCGJUL7K',,[8&YG&D#^Q$%$)BE1?BV2_=^IU>MU!KX<1[ED_/89P
M',=@B_KD_8#<P3CR/6M,78LD[7@>>>+:D)"EY%;:!I:1@*F7-=N0$)8%*PR]
M;@H4]70<?;:6C>BX9%@(J![@QP#KKD!Q7_\(.+%G4)HSN6YNJKC<+I,86MTK
M*&[V']&JKTV@Y*O(HN9YQS5G?V!H=?N@N.M_1 ND-F [?XK\X'>Y1;'?][H^
MQE:W#XI[?SF#8UCY'D;!!?H4:V.T[AP4M_P[&4%.@I7,L$;6(N)?]$_['E[L
M=9.@N+?/A(&F*A>$^K_.?R,ACPH%V6K$PI4F,DW!,$(CHY<3\O.91TG.%'EE
M28&M3VC=."AN[C/%8I$M2;A)YS)I),0%'L/@%EO6UOW!Q\W\/4OD^BU:L6S)
M#ZX 6H3NG\-KC*CN!_Y1_> ZY6II<_0%%,P*RCW-6=8XFRV";<M*?V\3@)OS
M$V3*\,RRI$6V:Z2Z$0D7:D6J'=['+3F4B8B$L8GZ!@:J!&LLIQ:55I[:UGW<
M@@/%3R-(#P<'WVY(8$\ 6Z?OBT6S0[3HM9+5KN[C'OP_LJG6!9"U N*R!P'=
MO>VP_6D!]A)0SYHD? %"WED?=-5VM[X],3(O=\AS:6"_71ZN. ,V.P#N+Z0T
M[R=VTUW]9C+Z%U!+ P04    " "#4FA6GZ ;\+$"  #B#   #0   'AL+W-T
M>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/Z
MZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N
M6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2
MK"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(
M&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=
MJ?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-
M9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]
MK;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LU
MF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>
MDO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A
M'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[
M7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..V
MBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/
M9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>
MF*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%'
M, ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "#4FA6EXJ[',     3
M @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/
MV!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"
MKM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%"
M:4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0
MT^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( (-2:%8<
M.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+
M5$2XE#Z0JA:5BON2=8C%/B*O RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(
MA:Z9FWF6I;(&;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU
M$QE*QA@$[( =PCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&
M;4N*SA5Z,@QV0(SE'WC;B?PT^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+
M\0D= ZT,PS/%ML%PZ&C$179EH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:
MFZ15,!X*/:XH$ZQZ#"PAJ748J&2W<RJGUW9PS2+W*D.:HPQH;0?AHUH+%0:P
M;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "#
M4FA6)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
MM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)
M3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8
M,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):B
MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " "#4FA6!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (-2:%:H(RXP
M[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( (-2:%:97)PC$ 8  )PG   3              "  <L!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ @U)H5A#O!A]P!   /Q$
M !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( (-2:%:?H!OPL0(  .(,   -              "  ;(,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ @U)H5I>*NQS     $P(   L
M         ( !C@\  %]R96QS+RYR96QS4$L! A0#%     @ @U)H5APX9>H_
M 0  / (   \              ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( (-2:%8D'INBK0   /@!   :              "  >,1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (-2:%9ED'F2&0$
M ,\#   3              "  <@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  !(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10049447_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  brhc10049447_8k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="brhc10049447_8k.htm">brhc10049447_8k.htm</File>
    <File>brhc10049447_ex99-1.htm</File>
    <File>brhc10049447_ex99-2.htm</File>
    <File>brhc10049447_ex99-3.htm</File>
    <File>brhc10049447_ex99-4.htm</File>
    <File>usph-20230302.xsd</File>
    <File>usph-20230302_lab.xml</File>
    <File>usph-20230302_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10049447_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10049447_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "usph-20230302_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "usph-20230302_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "usph-20230302.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "usph",
   "nsuri": "http://usph.com/20230302",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049447_8k.htm",
      "contextRef": "c20230302to20230302",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://usph.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10049447_8k.htm",
      "contextRef": "c20230302to20230302",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001140361-23-010614-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-010614-xbrl.zip
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M?8'\FS,T:)$EAJ4NV-MKG@O;@"'RA)K#]Z/+#P.A^; :GM]6I8'0AMA[?($
MV<4(=>6OV#AZT;D@3.FM/YU/*ST$R0)VEGRT6KJV_PB>:))M<TH."& ;\@Y>
MU0+CE+4)+M='O&G6[V7(H[% 0(IZ@1@;V/K\=G7L6=^W.-9Q9V[6_0WW"S#4
MJ]E%VQON#X7THE80QGN-[:X;;6G(-]KNI:;O;[_O0Y85$HQ '3&I\(5NPTU\
M8EF.2I/<9'VCN%(O %H(\['D,F M)PKG294@6- B,]R/ !X4U !_!V1IBD*&
MZD/J8 S @^8)?#['@O)=R1R<0M$Q\2P5:FBC=PCRVLKMQQ]S=B7U%GI7:6%3
M*JJYE5EA(? -0V^5>AN?YI@/4=@!&'-%4=:&S6.Q@H,*/C>])3PG^>E)O%8Q
M9Y3.+B9^[TF9:  S5 ,J\P(EULB0378!8\14EI;K1\!E53!64](_-BZK@3&D
M31,X+[F"K"J]YT1NCP1C2PBL.O3O&XS5]5OMY06XW:S;JK1H5G-L'N,4"$VW
M&_@UGTF\UP#"9-%:Q+6N.$-JJ\6M"BY;+7WAD.R'B:4<TV32!28A[Q%O/""*
MLK>QK6\>3FGHPWVB*Z#*!8 C>]B0;&1/AEA(G1Q"L* U8:]D<B<"(V&@_&EA
M ;-'O8S%^V;A2(' M0H!:A6RTA+BEHL&#4$C!T+)DH0&J)P+TH/TGE>4P6 M
MZ)2Z88TA0M/16F..6J4]6U'.4TS"D%IK,1/#E>!2A)= :-CFD%&'G$85?2T,
M&#PG/IX29+%60$;UMF'D<OY -*^$]7!\:;GDMYG$0UE=3!$)-EC@+<:<E*UE
M_:M2 (<H\7.5%CC]:^BQQ9!%&DW-I)5L*-H7&.H]]]",(GTJQ2 &@NK"P\"*
M(ATP0XGSK65E/<66_&;H/1IXWUM4H9LP-=A&U4Y=133(1,_!@44.X@+.  [6
MQR!))H:!X7C9ZP(ASJ@O< ),_WPZ:R=@Z"3II2FA$DGG%DY,L-S:@=(31B3
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M&-A1X-DV6'G.(/0VZ)3SF\#\2D_<YF'^=Y6_QZCMDY/S)<,.45_0M#[K%!_
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MF[$P.6&:0Q%X-583HZE]$:MID>:ZGPLA%1N7U>><(B#DE.HHU_MG[5G(IJ6
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M!?<#RH0;!XGEQ<Z6V)]I^&9Y<H6JBC+6:!5F4LZPZ7Q&2S%3&68R,#6?-SD
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M<FAC,3 P-#DT-#=?97@Y.2TS+FAT;5!+ 0(4 Q0    ( (-2:%93/(?0S0\
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H:"TR,#(S,#,P,E]P<F4N>&UL4$L%!@     (  @ &@(  $-G      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
